So we've been selling Zorvolex for 2 months, and I can't see a lot of interest in another diclofenac. I don't think there will be any interest in a has been poor side effect drug like indomethacin. Hey, it's a job.
As soon as the efficacy study vs. Aspirin is complete. Hey, it will have less systemic exposure and be effective. Yesssirree!
I can't wait to sell this. I think once Zorvolex gets the OA indication along with selling Tiforbex we are gonna see big things. Docs will see the big picture.